Plunkett Research Online: Orgenesis Inc

ORGENESIS INC (ORGS:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Orgenesis is a development stage company with a novel therapeutic approach in the treatment of diabetes by correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. Orgenesis employs a molecular and cellular approach directed at converting liver cel.....



Orgenesis Inc
Ticker: ORGS
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 503 206-0935
Fax:
Address: 20271 Goldenrod Lane
Germantown, MD 20876 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Tissue Engineering
ContactsDescription
Scott CarmerCEO, Subsidiary
Jacob BenArieCEO, Subsidiary/President, Subsidiary
See More
Orgenesis is a development stage company with a novel therapeutic approach in the treatment of diabetes by correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. Orgenesis employs a molecular and cellular approach directed at converting liver cel.....See More See More

Auditor: Kesselman & Kesselman C.P.A.s
Legal Advisor: Gersten, Savage, Kaplowitz, Wolf & Marcus, LLP
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: